Skip to content
🧬 New: 3 PDRN clinical studies added this weekπŸ”¬ 120+ PDRN products compared β€” find your matchπŸ“© Free weekly PDRN research digest β€” subscribe below
PDRN Care
WikiCell Biology

Endothelial Cells

Dr. Sarah Chen

Dr. Sarah Chen

PhD, Molecular Biology

4 minMay 1, 2026
Definition

Endothelial cells are specialized squamous cells that form the endothelium β€” the single-cell-thick lining of all blood vessels, from large arteries to dermal capillaries [1].

Definition

Endothelial cells are specialized squamous cells that form the endothelium β€” the single-cell-thick lining of all blood vessels, from large arteries to dermal capillaries [1]. In the skin, the dermal microvasculature is composed entirely of endothelial cells arranged into capillary networks that supply oxygen, nutrients, and growth factors to the dermis and epidermis [1][4]. Endothelial cells are a primary cellular target of PDRN-mediated angiogenesis, the process by which new blood vessels form from pre-existing vasculature [2][3].

Functions in the Skin

Nutrient and Oxygen Delivery

The dermal microvascular network, built from endothelial cells, is the sole supply line for the avascular epidermis [1]. Oxygen, glucose, amino acids, and signaling molecules diffuse from capillary loops in the papillary dermis upward into the epidermis, sustaining keratinocyte proliferation and barrier function [1][4]. When this microvascular network deteriorates β€” as it does with aging and photodamage β€” epidermal thinning, delayed healing, and impaired skin quality follow [4].

Angiogenesis

Endothelial cells are the effector cells of angiogenesis [4]. When tissue requires increased blood supply β€” during wound healing, after injury, or in response to growth factor signaling β€” endothelial cells activate, proliferate, migrate toward the angiogenic stimulus, and organize into new capillary tubes [1][4]. This process is governed primarily by vascular endothelial growth factor (VEGF), which binds to VEGF receptors on the endothelial surface [4].

Vascular Permeability and Signaling

Beyond forming vessel walls, endothelial cells actively regulate vascular permeability, controlling which molecules and immune cells pass from the blood into surrounding tissue [1]. They secrete nitric oxide (NO) for vasodilation, prostacyclin to prevent clotting, and a range of cytokines and growth factors that influence surrounding fibroblasts, pericytes, and immune cells [1][4].

Endothelial Cells and Skin Aging

Aging and cumulative UV exposure progressively damage the dermal microvasculature [4][5]:

  • Capillary loss β€” The density of dermal capillary loops decreases with age, reducing nutrient delivery to the epidermis and contributing to epidermal thinning [4]
  • Endothelial dysfunction β€” Aged endothelial cells produce less NO and respond more weakly to angiogenic signals, resulting in impaired vascular repair [1][4]
  • Reduced VEGF expression β€” Declining growth factor levels in the aging dermis diminish the capacity for new vessel formation [4]
  • Basement membrane thickening β€” Accumulation of collagen IV and laminin around capillaries impedes diffusion and nutrient exchange [1]

The loss of functional microvasculature creates a vicious cycle: reduced blood supply impairs fibroblast function, which further reduces the growth factor signaling needed to maintain vessels [4][5].

PDRN and Endothelial Cell Activation

PDRN directly and indirectly activates endothelial cells to restore dermal angiogenesis [2][3][5]:

VEGF Upregulation

PDRN stimulates the expression of VEGF in the dermis through adenosine A2A receptor-mediated signaling [2][3]. Increased VEGF availability activates endothelial cells, triggering their proliferation, migration, and tube formation β€” the three steps required for new capillary growth [2][4]. In the diabetic wound model, PDRN-treated tissue showed significantly higher VEGF levels and capillary density compared to untreated controls [2].

Endothelial Proliferation

Beyond VEGF-mediated effects, PDRN provides nucleotide building blocks through the salvage pathway that support the DNA replication demands of rapidly dividing endothelial cells [3][5]. This dual mechanism β€” receptor-mediated activation plus metabolic substrate supply β€” enhances the efficiency of new vessel formation [3].

Restoration of Microvascular Networks

By promoting angiogenesis, PDRN helps rebuild the capillary density lost to aging and photodamage [2][3][5]. Improved microcirculation restores oxygen and nutrient delivery to the dermis and epidermis, creating a supportive environment for fibroblast activation, collagen synthesis, and overall skin quality improvement [2][5].

Clinical Significance

The endothelial-activating properties of PDRN have several clinical implications [2][3]:

  • Wound healing β€” Enhanced angiogenesis is critical for healing chronic and ischemic wounds where inadequate blood supply is the primary barrier to repair [2]
  • Skin rejuvenation β€” Restored microvascular density improves skin color, luminosity, and the "glow" associated with healthy, well-perfused skin [3][5]
  • Post-procedure recovery β€” Increased capillary formation accelerates healing after laser, microneedling, and other ablative procedures [3]
  • Synergy with fibroblasts β€” The new vasculature PDRN promotes delivers oxygen and nutrients that support the concurrent fibroblast activation and collagen synthesis PDRN stimulates [2][3]

The vascular improvements from PDRN treatment contribute to the progressive, cumulative nature of clinical results β€” new capillary networks take weeks to mature and stabilize, paralleling the timeline of collagen remodeling [2][3].

Reviewed by Dr. Min-Ji Park, MD, Board-Certified Dermatologist

References

  1. [1]
    Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med. 2012;2(1):a006429. doi:10.1101/cshperspect.a006429
  2. [2]
    Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
  3. [3]
    Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  4. [4]
    Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298-307. doi:10.1038/nature10144
  5. [5]
    Colangelo MT, Galli C, Giannelli M. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056. doi:10.2174/1381612826666200113091648
ShareTwitterLinkedIn

Search

Search across products, blog posts, wiki articles, and more.